We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
The ductus arteriosus is a blood vessel connecting the aorta to the pulmonary artery. It spontaneously closes after birth in the majority of infants born at full term, and this is essential in order for the baby to survive. However, in premature babies, closure of the ductus arteriosus is often delayed until more than a week after being born.
The most common clinical sign is the onset of a murmur under the left collar bone. Patent ductus arteriosus may be accompanied by a high heart rate and rapid breathing and also increased pulmonary flow. This increase produces congestion which prevents development of the lungs in premature babies.
It principally affects premature babies. Patent ductus arteriosus affects 30% of premature babies weighing under 1500g.
Patent ductus arteriosus is detected via echocardiogram.
When the patent ductus arteriosus affects the new-born’s health, initial treatment is medical and pharmacological.
Indometacin is the standard treatment for closing the ductus arteriosus with medication. Ibuprofen can also be used as this anti-inflammatory gives good results in these cases.
The usual treatment would be closure via catheterization. This means inserting a catheter into the ductus arteriosus to close it. This type of closure would normally be used for babies with ductus arteriosus under 3 mm diameter and who are of a suitable weight.
Surgical treatment is reserved for patients where pharmacological treatment has failed, or where it is not advisable, and for cases where catheterization is not recommended.
Prognosis is excellent both for closure through catheterization and surgery. The recanalization rate of patent ductus arteriosus is estimated at 0-3 %.
Paediatric Intensive Care
Gastroenterology, Hepatology, Nutritional Support and Paediatric Hepatic Transplants
Gynaecology
Foetal Medicine
Paediatric Oncology and Haematology
Obstetrics Ultrasound Unit
Social Obstetrics Unit
Cardiac Surgery
Gynaecological Oncology and Pathology of the Lower Genital Tract
Diagnostic and Interventional Haemodynamics
Physical Medicine and Rehabilitation
Paediatrics
Prenatal Diagnosis Unit
Perinatal Mental Health Unit
General and Digestive Surgery
Paediatric Cardiac Surgery
Paediatric Urology
Paediatric Nephrology
Pneumology, allergology and cystic fibrosis
Diabetes and Pregnancy Unit
Hepatobiliary and Pancreatic Surgery and Transplants
Paediatric Orthopaedic Surgery
Obstetric and Gynaecological Emergency Care
Neurosurgery
Paediatric Hospitalisation and Hospital Paediatrics Unit
Gynaecological Endocrinology
Neonatology
Paediatric Maxillofacial Surgery
Paediatric Digestive Surgery and Transplants
Sleep Unit
Clinical Neurophysiology
Paediatric emergency care
Paediatric and Adolescent Gynaecology
Anaesthesia, Resuscitation and Pain Management
Neonatal and Foetal Surgery
Endocrine, Metabolic, and Bariatric Surgery
Nutritional Support
Congenital Heart Disease in Adolescents and Adults
Paediatric Surgery
Prematurity Prevention Unit
Arrhythmia Unit
Plastic Surgery and Burns
Gynaecological Endoscopic Surgery
Breast Pathology
Paediatric Neurology
Paediatric Oncological Surgery Unit
Foetal Medicine and Surgery Unit
Paediatric Cardiology
Pharmacy
Paediatric Endocrinology
Paediatric Infectious Diseases and Immunodeficiencies Unit
Paediatric Ophthalmology
Hereditary Angioedema Unit
Obstetrics and Reproductive Medicine
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.